Aura Biosciences, Inc. (AURA) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $59.52M | +87.8% |
| 2024 | $31.69M | -22.8% |
| 2023 | $41.06M | -66.2% |
| 2022 | $121.58M | -18.4% |
| 2021 | $149.06M | +757.0% |
| 2020 | $17.39M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $59.52M | +87.8% |
| 2024 | $31.69M | -22.8% |
| 2023 | $41.06M | -66.2% |
| 2022 | $121.58M | -18.4% |
| 2021 | $149.06M | +757.0% |
| 2020 | $17.39M | — |